The Technical Analyst
Select Language :
Sonoma Pharmaceuticals [SNOA]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Sonoma Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Sonoma Pharmaceuticals is listed at the  Exchange

0.73% $0.166

America/New_York / 28 mar 2024 @ 16:00


Sonoma Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2.60 mill
EPS: -0.820
P/E: -0.200
Earnings Date: Jun 18, 2024
SharesOutstanding: 15.61 mill
Avg Daily Volume: 1.962 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.200 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.200 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.149 - 0.183

( +/- 10.22%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-29 Trombly Amy Moss Buy 60 000 Stock option (right to buy)
2023-12-29 Thornton Bruce Buy 60 000 Stock option (right to buy)
2023-12-29 Dal Poggetto John Buy 50 000 Stock option (right to buy)
2023-12-29 Dvonch Jerome J Buy 60 000 Stock option (right to buy)
2023-07-17 Dal Poggetto John Sell 5 000 Stock option (right to buy)
INSIDER POWER
85.49
Last 96 transactions
Buy: 1 783 187 | Sell: 474 451

Forecast: 16:00 - $0.166

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.166
Forecast 2: 16:00 - $0.166
Forecast 3: 16:00 - $0.166
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.166 (0.73% )
Volume 3.26 mill
Avg. Vol. 1.962 mill
% of Avg. Vol 165.95 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Sonoma Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Sonoma Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Sonoma Pharmaceuticals Inc

Last 10 Buy & Sell Signals For SNOA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Sonoma Pharmaceuticals Inc

SNOA

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.

Last 10 Buy Signals

Date Signal @
LEOUSDMar 29 - 07:346.06
YFIIUSDMar 29 - 07:30$609.96
PAXGUSDMar 29 - 07:302 210.17
XAUTUSDMar 29 - 07:19$2 232.78
POLYXUSDMar 29 - 07:190.529
VRXUSDMar 29 - 07:1862.71
TOMOUSDMar 29 - 07:13$1.061
POOLXUSDMar 29 - 07:095.22
COREUSDMar 29 - 07:086 994.98
PENDLEUSDMar 29 - 07:094.21

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.